DD133672A5 - Verfahren zur herstellung eines saeureadditionssalzes - Google Patents

Verfahren zur herstellung eines saeureadditionssalzes

Info

Publication number
DD133672A5
DD133672A5 DD7600202338A DD20233876A DD133672A5 DD 133672 A5 DD133672 A5 DD 133672A5 DD 7600202338 A DD7600202338 A DD 7600202338A DD 20233876 A DD20233876 A DD 20233876A DD 133672 A5 DD133672 A5 DD 133672A5
Authority
DD
German Democratic Republic
Prior art keywords
saeure
producing
additional salt
salt
additional
Prior art date
Application number
DD7600202338A
Other languages
German (de)
English (en)
Inventor
Ronnie D Carroll
James R Tretter
Bernard S Moore
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD133672A5 publication Critical patent/DD133672A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD7600202338A 1975-10-03 1976-09-27 Verfahren zur herstellung eines saeureadditionssalzes DD133672A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/619,302 US4011231A (en) 1975-10-03 1975-10-03 2-Phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4H-pyrido[3,2-d]-1,3-dioxin maleate and its use as an intermediate

Publications (1)

Publication Number Publication Date
DD133672A5 true DD133672A5 (de) 1979-01-17

Family

ID=24481329

Family Applications (2)

Application Number Title Priority Date Filing Date
DD7600202338A DD133672A5 (de) 1975-10-03 1976-09-27 Verfahren zur herstellung eines saeureadditionssalzes
DD7600195004A DD129325A5 (de) 1975-10-03 1976-09-27 Verfahren zur herstellung von 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-teert.-butylaminoaethyl)-pyridin

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD7600195004A DD129325A5 (de) 1975-10-03 1976-09-27 Verfahren zur herstellung von 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-teert.-butylaminoaethyl)-pyridin

Country Status (30)

Country Link
US (1) US4011231A (xx)
JP (1) JPS5246081A (xx)
AR (1) AR213180A1 (xx)
AT (1) AT353789B (xx)
BE (1) BE846471A (xx)
BG (1) BG27544A3 (xx)
CA (1) CA1059518A (xx)
CH (1) CH616424A5 (xx)
CS (2) CS205042B2 (xx)
DD (2) DD133672A5 (xx)
DE (1) DE2640123C3 (xx)
DK (1) DK147049C (xx)
ES (2) ES451746A1 (xx)
FI (1) FI64354C (xx)
FR (1) FR2326191A1 (xx)
GB (1) GB1510075A (xx)
GR (1) GR61628B (xx)
HU (2) HU177493B (xx)
IE (1) IE43503B1 (xx)
LU (1) LU75898A1 (xx)
NL (1) NL164274C (xx)
NO (1) NO147027C (xx)
PH (1) PH14511A (xx)
PL (1) PL106863B1 (xx)
PT (1) PT65619B (xx)
RO (1) RO69886A (xx)
SE (2) SE428127B (xx)
SU (2) SU673168A3 (xx)
YU (1) YU39545B (xx)
ZA (1) ZA765253B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632992A (en) * 1981-02-09 1986-12-30 Pfizer Inc. Intermediates for preparing pirbuterol and analogs
US4477671A (en) * 1981-02-09 1984-10-16 Pfizer Inc. 3-Acetoxy or benzyloxy-2-acetoxymethyl-6-[1-acetoxy-2-(N-tert-butylacetamido)ethyl]pyridine intermediates
US5395939A (en) * 1993-11-30 1995-03-07 North Carolina State University Method of making asymmetric de ring intermediates for the synthesis of camptothecin and camptothecin analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250778A (en) * 1962-11-29 1966-05-10 Hoffmann La Roche Intermediates for and synthesis of vitamin b and related compounds
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines

Also Published As

Publication number Publication date
LU75898A1 (xx) 1977-05-11
SE8003311L (sv) 1980-04-30
PT65619B (en) 1978-04-05
NO147027B (no) 1982-10-11
SE428127B (sv) 1983-06-06
BG27544A3 (en) 1979-11-12
ATA692376A (de) 1979-05-15
ES457257A1 (es) 1978-02-01
RO69886A (ro) 1981-09-24
YU39545B (en) 1984-12-31
PL106863B1 (pl) 1980-01-31
GB1510075A (en) 1978-05-10
DK147049B (da) 1984-03-26
IE43503B1 (en) 1981-03-11
ZA765253B (en) 1977-08-31
DD129325A5 (de) 1978-01-11
DK147049C (da) 1984-10-01
NO147027C (no) 1983-01-19
FR2326191B1 (xx) 1978-11-17
DE2640123A1 (de) 1977-04-07
NL164274B (nl) 1980-07-15
CA1059518A (en) 1979-07-31
SE437159B (sv) 1985-02-11
CS205042B2 (en) 1981-04-30
AR213180A1 (es) 1978-12-29
IE43503L (en) 1977-04-03
FI64354B (fi) 1983-07-29
SU673168A3 (ru) 1979-07-05
PT65619A (en) 1976-10-01
DE2640123C3 (de) 1980-09-25
SE7609497L (sv) 1977-04-04
NO763307L (xx) 1977-04-05
BE846471A (fr) 1977-03-23
ES451746A1 (es) 1977-08-16
DK434176A (da) 1977-04-04
NL7610683A (nl) 1977-04-05
HU177493B (en) 1981-10-28
FI762693A (xx) 1977-04-04
HU172998B (hu) 1979-01-28
NL164274C (nl) 1980-12-15
PH14511A (en) 1981-08-24
US4011231A (en) 1977-03-08
SU725562A3 (ru) 1980-03-30
AU1788376A (en) 1978-03-16
JPS5519210B2 (xx) 1980-05-24
FI64354C (fi) 1983-11-10
JPS5246081A (en) 1977-04-12
YU216576A (en) 1982-06-30
GR61628B (en) 1978-12-04
AT353789B (de) 1979-12-10
FR2326191A1 (fr) 1977-04-29
CH616424A5 (xx) 1980-03-31
DE2640123B2 (de) 1980-01-31
CS205041B2 (en) 1981-04-30

Similar Documents

Publication Publication Date Title
DD133519A5 (de) Verfahren zur herstellung eines stuetzverbands
AT352509B (de) Verfahren zur herstellung eines aufstrich- mittels mit niedrigem fettgehalt
DD132786A5 (de) Verfahren zur herstellung eines neuen oximaethers
AT369429B (de) Verfahren zur herstellung eines teilreduzierten produktes
AT346228B (de) Verfahren zur herstellung eines kunststoff- -fasses
AT352913B (de) Verfahren zur herstellung eines neuen vincaminsalzes
AT348315B (de) Verfahren zur herstellung eines aufstrich- mittels mit niedrigem fettgehalt
AT363569B (de) Verfahren zur herstellung eines tantal-duennschichtkondensators
AT357407B (de) Verfahren zur herstellung eines speckaehnlichen produktes
AT360512B (de) Verfahren zur herstellung eines d-enantiomeren indolderivats
AT351914B (de) Verfahren zur herstellung eines aufstrich- mittels mit niedrigem fettgehalt
AT358792B (de) Verfahren zur herstellung eines doppelbodens
AT348141B (de) Verfahren zur herstellung eines neuen 6-methyl- 8- (substituierten) methylergolins
AT366056B (de) Verfahren zur herstellung eines phosphordichloridothiolats
AT339253B (de) Verfahren zur herstellung eines reinen ceroxids
AT358723B (de) Verfahren zur herstellung eines lipasereichen enzympraeparates
AT362214B (de) Verfahren zur herstellung eines schichtstoffes
DD133672A5 (de) Verfahren zur herstellung eines saeureadditionssalzes
AT357855B (de) Verfahren zur herstellung eines pektin- praeparates
AT347316B (de) Verfahren zur herstellung eines kapsel- empfindlichen gelierten sprengstoffes
DD132259A5 (de) Verfahren zur herstellung von synthetischem flussspat
AT348163B (de) Verfahren zur herstellung eines neuen prostaglandinderivates
AT365615B (de) Verfahren zur herstellung eines latex
DD124541A1 (de) Verfahren zur herstellung eines pastenfoermigen hydrophobiermittels
DD135614A1 (de) Verfahren zur herstellung eines stabilen gold-aminsulfitkomplexes